Carbapenem-resistant Klebsiella oxytoca transmission linked to preoperative shaving in emergency neurosurgery, tracked by rapid detection via chromogenic medium and whole genome sequencing

Front Cell Infect Microbiol. 2024 Oct 17:14:1464411. doi: 10.3389/fcimb.2024.1464411. eCollection 2024.

Abstract

Objectives: This study describes the detection and tracking of emergency neurosurgical cross-transmission infections with carbapenem-resistant Klebsiella oxytoca (CRKO).

Methods: We conducted an epidemiological investigation and a rapid screening of 66 surveillance samples using the chromogenic selective medium. Two CRKO isolates from infected patients and three from the preoperative shaving razors had similar resistance profiles identified by the clinical laboratory.

Results: The whole genome sequencing (WGS) results identified all isolates as Klebsiella michiganensis (a species in the K. oxytoca complex) with sequence type 29 (ST29) and carrying resistance genes bla KPC-2 and bla OXY-5, as well as IncF plasmids. The pairwise average nucleotide identity values of 5 isolates ranged from 99.993% to 99.999%. Moreover, these isolates displayed a maximum genetic difference of 3 among 5,229 targets in the core genome multilocus sequence typing scheme, and the razors were confirmed as the contamination source. After the implementation of controls and standardized shaving procedures, no new CRKO infections occurred.

Conclusion: Contaminated razors can be sources of neurosurgical site infections with CRKO, and standard shaving procedures need to be established. Chromogenic selective medium can help rapidly identify targeted pathogens, and WGS technologies are effective mean in tracking the transmission source in an epidemic or outbreak investigation. Our findings increase the understanding of microbial transmission in surgery to improve patient care quality.

Keywords: Klebsiella oxytoca; carbapenems; infections; surgery; whole genome sequencing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carbapenem-Resistant Enterobacteriaceae / drug effects
  • Carbapenem-Resistant Enterobacteriaceae / genetics
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification
  • Carbapenems / pharmacology
  • Chromogenic Compounds
  • Cross Infection / microbiology
  • Female
  • Genome, Bacterial / genetics
  • Humans
  • Klebsiella Infections* / microbiology
  • Klebsiella Infections* / transmission
  • Klebsiella oxytoca* / drug effects
  • Klebsiella oxytoca* / genetics
  • Klebsiella oxytoca* / isolation & purification
  • Male
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing*
  • Neurosurgical Procedures / adverse effects
  • Plasmids / genetics
  • Whole Genome Sequencing*
  • beta-Lactamases / genetics

Substances

  • Carbapenems
  • Anti-Bacterial Agents
  • beta-Lactamases
  • Chromogenic Compounds

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Natural Science Foundation of the Republic of China (No. 82202572), the Anqing municipal medical category of science and technology project (No. 2023Z2019), and the Natural Science Research Project Funding of Higher Education Institutions of Anhui Province (No. KJ2021A0321, No. KJ2021A0332; No. 2023AH053175).